According to a recent report from MarketsandMarkets, North America is expected to control a major share of the liquid handling market this year. This growth comes as a result of rising cases of chronic disease spurring a demand for research on regenerative medicine and genetics.
The biotechnology industry has shown advancements in the regeneration of cells, tissues, and organs, which have promising applications for many age-related diseases such as macular degeneration, Parkinson’s disease, and Alzheimer’s disease. These potential developments have led to larger investments in the biotechnology and pharmaceutical sectors. The biotechnology market alone is expected to be worth $727.1 billion by 2025, a growth rate of 7.4% (Source: Grand View Research).